Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Remifentanil Site-effect Concentration for Preventing Severe Cough and Hyperdynamic Response During Tracheal Extubation After Sevoflurane vs. Desflurane. A Randomized Clinical Trial

NCT03132519 is registered in ClinicalTrials.gov with Fundacion Clinica Valle del Lili as lead sponsor.

NCT NCT03132519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03132519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Remifentanil Site-effect Concentration for Preventing Severe Cough and Hyperdynamic Response During Tracheal Extubation After Sevoflurane vs. Desflurane. A Randomized Clinical Trial
Lead sponsor
Fundacion Clinica Valle del Lili
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2013
Completion date
February 29, 2016
Enrollment
364 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cough, hypertension